SP Scientific introduces new range of Hotpack glassware washers
Technological developments allow the new washers to deliver enhanced drying performance from an upgraded dual fan system incorporated in the washer chambers.
SP Scientific has introduced a new range of Hotpack undercounter and doublestack glassware washers that are engineered for productive, reliable and energy efficient operation.
Technological developments allow the new washers to deliver enhanced drying performance from an upgraded dual fan system incorporated in the washer chambers. Wash cycles with temperatures up to 70 °C (158 °F) enable fast, efficient cleaning of different types of glassware in wide ranging load scenarios. New soft touch features with multiple cycle selections and microprocessor control systems ensure that each load is processed with minimum energy consumption. A delayed start function allows the washer to operate unattended during off-peak hours to further reduce energy costs.
An attractive new design and ultra-quiet operation ensure that the Hotpack undercounter washers enhance any laboratory environment. Manufactured from insulated 304 stainless steel ensures long-term corrosion protection plus maintains a superior cosmetic appearance.
The new Hotpack washers feature loading and operation flexibility to accommodate a wide range of specialty baskets that fit into upper and lower racks. Safeguarding customer investment the new washers are fully compatible with previous generations of Hotpack washer racks and accessories.
Easy to use and maintain, each Hotpack glassware washer incorporates three separate filters, conveniently located for quick access, to protect pumps from washing debris.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.